What is it about?
We have developed a chemogenomics approach for selecting approved drugs to be tested against Schistosoma mansoni, the causative agent of the neglected tropical disease Schistosomiasis.
Featured Image
Why is it important?
To accelerate the drug discovery process for neglected tropical diseases.
Read the Original
This page is a summary of: In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni, PLoS Neglected Tropical Diseases, January 2015, PLOS,
DOI: 10.1371/journal.pntd.0003435.
You can read the full text:
Contributors
The following have contributed to this page
